Alzheimer's Disease Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who are willing and able to sign a consent form agreeing to take part in the study.
- People who meet the specific requirements for the particular group (arm) of the trial they are being considered for (confirm with trial site).
Who may not be able to join:
- People who are not willing or able to provide signed consent to participate.
- People who may have difficulty following the study's procedures due to language differences or problems with memory or thinking.
- People who regularly take certain medications that may affect sleep, such as opioid pain medicines, benzodiazepines (a type of sedative), or non-benzodiazepine sleeping tablets (sometimes called Z drugs).
- People with a history of alcohol misuse, drug misuse, loss of consciousness, stroke or other blood vessel problems in the brain, head injury, epilepsy, brain infections, or other nervous system conditions.
- People who have been diagnosed with schizophrenia, severe depression, severe anxiety disorders, or other serious mental health conditions.
- People who have serious heart rhythm problems, a heart attack within the last 6 months, severe lung problems, kidney or liver failure, severe anaemia, severe digestive system diseases, cancer, or other serious health conditions.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Benyan Luo, Zhejiang University
Phone: 0571-87236537
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Hamilton Anxiety Rating Scale (HAM-A); Hamilton Depression Rating Scale (HDRS); Mini-Mental State Examination (MMSE); Montreal Cognitive Assessment (MoCA); Transcriptomic profile; Metabolic profiling; Self reported scales
Can't join this trial?
Data last synced from ClinicalTrials.gov: 9 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.